Neonc Technologies Holdings, Inc.
Status: Publicly traded
Direct answer
Neonc Technologies Holdings, Inc. is publicly traded on NASDAQ under the ticker NTHI.
Neonc Technologies Holdings, Inc. specializes in pioneering molecular advancements aimed at improving the targeted administration of therapies for central nervous system disorders. The company's leading pipeline candidate, NEO100, is presently undergoing Phase 2a clinical trials for the treatment of glioblastoma. Additionally, NEO212, a unique molecular construct chemically linking the chemotherapeutic agent...
Can you invest in Neonc Technologies Holdings, Inc.?
Yes. Neonc Technologies Holdings, Inc. is publicly traded on NASDAQ under the ticker NTHI.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Neonc Technologies Holdings, Inc.
Detailed equity research is provided by MarketSnap.